age1

About

Our expertise is at earliest stage possible. Launched from The Longevity Fund, we’ve backed some of the first longevity biotech companies to IPO and achieve clinical translation. We value pragmatism, rigor, and optimism.

Funding Stage

funding stage

Not Applicable

Membership Sources:

Focus Area

Build Innovation Networkright-arrow
Capital
Develop Advanced Technologiesright-arrow
Frontier Tech

Projects (0)

No projects added.